Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Johnson Controls International Downgraded from Buy to Hold by Analyst Scott Davis

Elaine Mendonca by Elaine Mendonca
January 31, 2024
in Breaking News
0
Finance_Capitalization
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On January 31, 2024, Johnson Controls International (NYSE:JCI) experienced a significant shift in its stock rating. Renowned analyst Scott Davis from Melius Research made the bold decision to downgrade the stock from Buy to Hold. This unexpected move caught the attention of investors and market enthusiasts alike.

While the exact reasons behind this downgrade remain undisclosed, it is believed that multiple factors influenced Davis’ decision. Although the research note provided by Melius Research could shed light on these factors, it is yet to be made public.

This development was swiftly reported by Fintel and MarketBeat, two prominent sources in the financial industry. Their real-time coverage of stock upgrades and downgrades has become invaluable for investors seeking up-to-date information.

As the market absorbs this news, many will eagerly await further insights into the reasoning behind this downgrade. Only time will tell how this decision will impact Johnson Controls International and its future prospects.

Johnson Controls International (JCI) Stock Performance Declines: A Challenging Day for Investors

On January 31, 2024, Johnson Controls International (JCI) experienced a decline in its stock performance. The stock was trading near the bottom of its 52-week range and below its 200-day simple moving average. The price of JCI shares dropped by $2.16, accounting for a 3.81% decrease since the market last closed. Additionally, after hours, the stock faced a further decline with a drop of $0.10. This downward trend suggests a challenging day for the company’s stock performance. Trading near the bottom of its 52-week range indicates that the stock was at a relatively low point compared to its performance over the past year. The stock’s position below its 200-day simple moving average suggests a longer-term downward trend. The decrease of $2.16 represents a significant drop of 3.81%. The after-hours trading drop of $0.10 adds to the negative sentiment surrounding JCI’s stock performance. Investors will likely closely monitor JCI’s future performance to determine if this decline is indicative of a longer-term trend or a temporary setback.

JCI Stock Performance on January 31, 2024: A Closer Look at Financial Indicators and Future Prospects

Title: JCI Stock Performance on January 31, 2024: A Closer Look at Financial Indicators

Introduction

On January 31, 2024, Johnson Controls International plc (JCI) experienced mixed performance in its financial indicators. This article will delve into the stock’s performance based on the provided data from CNN Money, focusing on total revenue, net income, and earnings per share.

Total Revenue Growth

JCI’s total revenue for the past year amounted to $26.79 billion, reflecting a 5.91% increase compared to the previous year. However, when compared to the previous quarter, the total revenue remained flat at $6.91 billion.

Net Income Fluctuations

The net income of JCI for the past year stood at $1.85 billion, representing a significant 20.69% increase compared to the previous year. However, the net income experienced a substantial decline of 47.66% since the previous quarter, amounting to $549.00 million.

Earnings per Share Performance

JCI’s earnings per share (EPS) for the past year amounted to $2.69, indicating a notable increase of 22.83% compared to the previous year. However, the EPS experienced a significant decline of 47.45% since the previous quarter, amounting to $0.80.

Analysis

JCI’s performance on January 31, 2024, reflects a mixed bag of results. While the company experienced overall growth in total revenue, net income, and earnings per share over the past year, there was a significant decline in these indicators during the last quarter.

The 5.91% increase in total revenue over the past year indicates that JCI has been successful in generating consistent growth. However, the flat revenue growth in the last quarter suggests that the company faced challenges in maintaining this momentum.

The 20.69% increase in net income over the past year demonstrates JCI’s ability to generate higher profits. However, the sharp decline of 47.66% in net income during the last quarter raises concerns about the company’s short-term profitability.

Similarly, the 22.83% increase in earnings per share over the past year showcases JCI’s ability to enhance shareholder value. However, the significant decline of 47.45% in EPS during the last quarter indicates a setback in profitability.

Conclusion

JCI’s stock performance on January 31, 2024, showed a mixed outcome in its financial indicators. While the company experienced growth in total revenue, net income, and earnings per share over the past year, there was a significant decline in these indicators during the last quarter.

Investors should closely monitor JCI’s future financial reports to assess whether the decline in net income and earnings per share is a temporary setback or a concerning trend. It is essential to consider other factors, such as market conditions and industry dynamics, to gain a comprehensive understanding of JCI’s stock performance and make informed investment decisions.

Tags: JCI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Cloud computing

Speculation Surrounds Potential Collaboration Between Remark Holdings and Microsoft

Technology Artificial intelligence Market Capitalization

Clorox Faces Challenges and Prolonged Recovery After CyberAttack

Alternative Energy Markets and money

Bearish Sentiment Surrounding Occidental Petroleum OXY Options Activity

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com